Initial investigation of the frequency and co-occurrence of PPVs from a limited panel of 163 disease genes in the BRCA1/2-carrier cohort indicated that the majority of nonsynonymous PPVs in the cancer genetics clinic will be novel VUSs (not present in the ESP6500 database). The gene discussed is BRCA1; the disease is cancer.